Two commercialized hematology products, Olverembatinib and Lisaftoclax, drive dual-engine growth with strong China market presenceNext-generation BTK protein degrader APG-3288 receives…
NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), today announced…
Lommel / Hamburg, 01/15/2026 – Aqua free, a leading provider of innovative drinking-water hygiene solutions, has successfully moved into its new,…
January 14, 2026 01:30 ET | Source: Orion Oyj ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION 14 JANUARY 2026 at…
14 abstracts will be presented across a range of neurological conditions including post‑stroke spasticity, cervical dystonia, blepharospasm and other movement…
— First randomized Phase III trial confirming the efficacy of MET inhibition in patients with advanced NSCLC and acquired MET…
Amsterdam City, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Weaviate, the AI database company, today announced it has been recognized as…
TORONTO, Jan. 13, 2026 (GLOBE NEWSWIRE) -- In a release issued under the headline "Visionary Holdings Inc. Reports Fiscal Year…
Renderforest expands its platform with its own proprietary AI model, enabling text, visuals, animation, audio, and scene regeneration inside one…
Not intended for US and UK audiences BI 765423 has been developed to target IL-11, a key driver of fibrosis…